OTCM
DHBUF
Market cap1mUSD
Oct 06, Last price
0.05USD
1D
-5.64%
1Q
-34.36%
IPO
-59.59%
Name
Delivra Health Brands Inc
Chart & performance
P/E
—
P/S
0.17
EPS
—
Div yield, %
—
Shrs. gr., 5y
7.81%
Rev. gr., 5y
9.78%
Revenues
13m
+8.01%
Net income
-874k
L
CFO
-554k
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Vancouver, Canada, Delivra Health Brands Inc., through its various subsidiaries, distributes an assortment of lifestyle and wellness goods to a global clientele of consumers and medical patients within regulated jurisdictions. The firm's product line includes cannabis, liquid sleep supplements, powdered sleep aids, edible gummies, and topical pain relief solutions. These items are available under well-known brand labels like LivRelief, Dream Water, and LivRelief Infused. The company was formerly recognized as Harvest One Cannabis Inc.
Key people
Aaron Wong
Chief Financial Officer · since 2019
Ann Gallery
Senior Vice President - Corporate Communications · since 2018
Will Stewart
Senior Vice President - Corporate and Public Affairs · since 2018
Deb Milimaka Miles
Chief Administrative Officer and Chief People Officer · since 2019
Kwong Choo
Vice President - Finance · since 2017
Andrew Malcolm Kain
Chief Operating Officer, General Counsel · since 2018
Executive Chairman of the Board · since 2020
Gord Davey
Senior Vice President of Global Sales · since 2018
Marien Segovia
Corporate Secretary · since 2018
Andy Bayfield
Interim Chief Executive Officer, Director · since 2020
President, Chief Executive Officer, Chief Financial Officer, Corporate Secretary, Director
Glen Macdonald
Director · since 2013
Peter Wall
Director · since 2018
David A. Berg
Independent Director · since 2009
Non-Executive Independent Director · since 2018
Headquarters & legal address
Suite 2650, 1066 West Hastings St.
Vancouver, BC V6E 3X1
CA
Vancouver, BC V6E 3X1
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||